Abstract

Polypept(o)ides combine the stealth-like properties of polypeptoids such as polysarcosine (poly(N-methyl glycine), pSar) with the multifunctionality and intrinsic stimuli-responsiveness of synthetic polypeptides. This class of copolymers can be synthesized by controlled living ring-opening polymerization of the corresponding α-amino acid N-carboxyanhydrides (NCAs) and N-substituted glycine N-carboxyanhydrides (NNCAs). When the polymerization is performed under clean conditions, the resulting copolymers are characterized by high end-group fidelity and Poisson-like molecular weight distributions with dispersities below 1.2. While pSar might be able to tackle most of the current concerns of poly(ethylene glycol) (PEG), e.g., acute immune responses, the polypeptide part can provide a plethora of reactivity or functionality, allowing to tailor the polymer for specific tasks. In this review, we provide an overview on the origins of NCA polymerization and polypept(o)ides and provide a detailed overview on the last decade of research focusing on synthesis, characterization, and application. Arguably the biggest applicational progress for polypept(o)ides has been made in nanomedicine. Here, the remarkable combination of functionality, biocompatibility and a high degree of synthetic control has led to established protocols for the certified production of polypept(o)ides, which will enable the rapid clinical translation for the years to come.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.